Works matching AU de Vries, Elisabeth G. E.
Results: 172
RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Whole-Body PET Imaging of Breast Cancer Characteristics to Improve Precision Treatment.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 5, p. 434
- By:
- Publication type:
- Article
Fluorescent image-guided surgery in breast cancer by intravenous application of a quenched fluorescence activity-based probe for cysteine cathepsins in a syngeneic mouse model.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13550-020-00688-0
- By:
- Publication type:
- Article
Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00627-z
- By:
- Publication type:
- Article
Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative <sup>18</sup>F-FDG PET/CT analysis.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0453-x
- By:
- Publication type:
- Article
Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 7, p. 1455, doi. 10.1002/ijc.33708
- By:
- Publication type:
- Article
Towards evidence-based response criteria for cancer immunotherapy.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38837-3
- By:
- Publication type:
- Article
Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment.
- Published in:
- mAbs, 2017, v. 9, n. 8, p. 1370, doi. 10.1080/19420862.2017.1371382
- By:
- Publication type:
- Article
ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody <sup>89</sup>Zr-RG7116.
- Published in:
- mAbs, 2014, v. 6, n. 4, p. 1051, doi. 10.4161/mabs.29097
- By:
- Publication type:
- Article
Routine bone scintigraphy in primary staging of soft tissue sarcoma; Is it worthwhile?
- Published in:
- 2000
- By:
- Publication type:
- journal article
Survival-Related Profile, Pathways, and Transcription Factors in Ovarian Cancer.
- Published in:
- PLoS Medicine, 2009, v. 6, n. 2, p. e1000024
- By:
- Publication type:
- Article
Translating Pharmacogenomics: Challenges on the Road to the Clinic.
- Published in:
- PLoS Medicine, 2007, v. 4, n. 8, p. e209, doi. 10.1371/journal.pmed.0040209
- By:
- Publication type:
- Article
Cigarette smoke extract affects functional activity of MRP1 in bronchial epithelial cells.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2007, v. 21, n. 5, p. 243, doi. 10.1002/jbt.20187
- By:
- Publication type:
- Article
Neuroendocrine tumours and their microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 8, p. 1449, doi. 10.1007/s00262-020-02556-1
- By:
- Publication type:
- Article
Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations.
- Published in:
- Molecular Imaging & Biology, 2023, v. 25, n. 2, p. 435, doi. 10.1007/s11307-022-01775-5
- By:
- Publication type:
- Article
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-023-00610-6
- By:
- Publication type:
- Article
Calcium or Resistant Starch Does Not Affect Colonic Epithelial Cell Proliferation Throughout the Colon in Adenoma Patients: A Randomized Controlled Trial.
- Published in:
- Nutrition & Cancer, 2002, v. 43, n. 1, p. 31, doi. 10.1207/S15327914NC431_3
- By:
- Publication type:
- Article
5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Variability in responsiveness to lovastatin of the primitive CD34<sup>+</sup> AML subfraction compared to normal CD34<sup>+</sup> cells.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 6, p. 573, doi. 10.1007/s00277-008-0633-2
- By:
- Publication type:
- Article
Video-rate optical flow corrected intraoperative functional fluorescence imaging.
- Published in:
- Journal of Biomedical Optics, 2014, v. 19, n. 4, p. 1, doi. 10.1117/1.JBO.19.4.046012
- By:
- Publication type:
- Article
Noise sensitivity of <sup>89</sup>Zr-Immuno-PET radiomics based on count-reduced clinical images.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00444-4
- By:
- Publication type:
- Article
The analysis of longitudinal quality of life measures with informative drop-out: a pattern mixture approach.
- Published in:
- Quality of Life Research, 2010, v. 19, n. 1, p. 137, doi. 10.1007/s11136-009-9564-1
- By:
- Publication type:
- Article
The HLA class III subregion is responsible for an increased breast cancer risk.
- Published in:
- Human Molecular Genetics, 2003, v. 12, n. 22, p. 3041, doi. 10.1093/hmg/ddg342
- By:
- Publication type:
- Article
The HLA class III subregion is responsible for an increased breast cancer risk.
- Published in:
- Human Molecular Genetics, 2003, v. 12, n. 18, p. 2311, doi. 10.1093/hmg/ddg245
- By:
- Publication type:
- Article
Differential regulation of IL-6 promoter activity in a human ovarian-tumor cell line transfected with various p53 mutants: Involvement of AP-1.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 2, p. 236, doi. 10.1002/(SICI)1097-0215(19990412)81:2<236::AID-IJC12>3.0.CO;2-R
- By:
- Publication type:
- Article
Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1.
- Published in:
- International Journal of Cancer, 1998, v. 76, n. 1, p. 55, doi. 10.1002/(SICI)1097-0215(19980330)76:1<55::AID-IJC10>3.0.CO;2-F
- By:
- Publication type:
- Article
Heat-shock protein expression in cisplatin-sensitive and -resistant human tumor cells.
- Published in:
- International Journal of Cancer, 1996, v. 67, n. 6, p. 800, doi. 10.1002/(SICI)1097-0215(19960917)67:6<800::AID-IJC8>3.0.CO;2-V
- By:
- Publication type:
- Article
Sensitization to cisplatin action by step-down heating in cddp-sensitive and -resistant cells.
- Published in:
- International Journal of Cancer, 1995, v. 61, n. 5, p. 722, doi. 10.1002/ijc.2910610521
- By:
- Publication type:
- Article
Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-<sup>18</sup>F-Fluoro-17β-Fluoroestradiol.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 351, doi. 10.2967/jnumed.123.265420
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in Mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1715, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer <sup>18</sup>F BMS-986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Assessment of Bone Lesions with <sup>18</sup>F-FDG-PET Compared to <sup>99m</sup>Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article